Analytical Data
-
Gene name
rpsC
- Application
-
Alternative Names
rpsC; b3314; JW3276; 30S ribosomal protein S3; Small ribosomal subunit protein uS3
-
Species
Escherichia coli
-
Source
E. coli
-
Tag
N- GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P0A7V3
-
Expression Region
2-233aa
-
Molecular Weight
52.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RpsC, the ribosomal protein S3, plays a crucial role in bacterial ribosome assembly and function, specifically in the decoding and translation processes. Research into RpsC is significant due to its vital involvement in protein synthesis, which is fundamental for bacterial growth and metabolism. Understanding RpsC at a molecular level can provide insights into the mechanisms of antibiotic action, as many antibiotics target the bacterial ribosome to inhibit protein synthesis. Moreover, because RpsC is highly conserved across different bacterial species, its study could lead to the development of broad-spectrum antibiotics. In recent years, advances in recombinant protein technology have facilitated the expression and purification of RpsC, allowing researchers to conduct detailed structural and functional analyses. These studies aim to elucidate the precise interactions of RpsC with ribosomal RNA and other ribosomal proteins, potentially revealing new therapeutic targets. Furthermore, understanding mutations in RpsC that confer antibiotic resistance could inform strategies to combat resistant strains. Overall, the research on recombinant RpsC not only enhances our fundamental understanding of ribosomal biology but also holds promising implications for medical and pharmaceutical applications in the fight against bacterial infections.
